Literature DB >> 23139156

Channel sialic acids limit hERG channel activity during the ventricular action potential.

Sarah A Norring1, Andrew R Ednie, Tara A Schwetz, Dongping Du, Hui Yang, Eric S Bennett.   

Abstract

Activity of human ether-a-go-go-related gene (hERG) 1 voltage-gated K(+) channels is responsible for portions of phase 2 and phase 3 repolarization of the human ventricular action potential. Here, we questioned whether and how physiologically and pathophysiologically relevant changes in surface N-glycosylation modified hERG channel function. Voltage-dependent hERG channel gating and activity were evaluated as expressed in a set of Chinese hamster ovary (CHO) cell lines under conditions of full glycosylation, no sialylation, no complex N-glycans, and following enzymatic deglycosylation of surface N-glycans. For each condition of reduced glycosylation, hERG channel steady-state activation and inactivation relationships were shifted linearly by significant depolarizing ∼9 and ∼18 mV, respectively. The hERG window current increased significantly by 50-150%, and the peak shifted by a depolarizing ∼10 mV. There was no significant change in maximum hERG current density. Deglycosylated channels were significantly more active (20-80%) than glycosylated controls during phases 2 and 3 of action potential clamp protocols. Simulations of hERG current and ventricular action potentials corroborated experimental data and predicted reduced sialylation leads to a 50-70-ms decrease in action potential duration. The data describe a novel mechanism by which hERG channel gating is modulated through physiologically and pathophysiologically relevant changes in N-glycosylation; reduced channel sialylation increases hERG channel activity during the action potential, thereby increasing the rate of action potential repolarization.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23139156     DOI: 10.1096/fj.12-214387

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  7 in total

1.  Reduced sialylation impacts ventricular repolarization by modulating specific K+ channel isoforms distinctly.

Authors:  Andrew R Ednie; Eric S Bennett
Journal:  J Biol Chem       Date:  2014-12-18       Impact factor: 5.157

2.  Sialic acids attached to N- and O-glycans within the Nav1.4 D1S5-S6 linker contribute to channel gating.

Authors:  Andrew R Ednie; Jean M Harper; Eric S Bennett
Journal:  Biochim Biophys Acta       Date:  2014-10-30

3.  Modulating Cell-Surface Receptor Signaling and Ion Channel Functions by In Situ Glycan Editing.

Authors:  Hao Jiang; Aimé López-Aguilar; Lu Meng; Zhongwei Gao; Yani Liu; Xiao Tian; Guangli Yu; Ben Ovryn; Kelley W Moremen; Peng Wu
Journal:  Angew Chem Int Ed Engl       Date:  2018-01-02       Impact factor: 15.336

4.  Pompe disease results in a Golgi-based glycosylation deficit in human induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Kunil K Raval; Ran Tao; Brent E White; Willem J De Lange; Chad H Koonce; Junying Yu; Priya S Kishnani; James A Thomson; Deane F Mosher; John C Ralphe; Timothy J Kamp
Journal:  J Biol Chem       Date:  2014-12-08       Impact factor: 5.157

5.  Limitations of galactose therapy in phosphoglucomutase 1 deficiency.

Authors:  Kristine Nolting; Julien H Park; Laura C Tegtmeyer; Andrea Zühlsdorf; Marianne Grüneberg; Stephan Rust; Janine Reunert; Ingrid Du Chesne; Volker Debus; Eric Schulze-Bahr; Robert C Baxter; Yoshinao Wada; Christian Thiel; Emile van Schaftingen; Ralph Fingerhut; Thorsten Marquardt
Journal:  Mol Genet Metab Rep       Date:  2017-07-31

Review 6.  Potassium channels in cell cycle and cell proliferation.

Authors:  Diana Urrego; Adam P Tomczak; Farrah Zahed; Walter Stühmer; Luis A Pardo
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-02-03       Impact factor: 6.237

7.  Neuraminidase-1 promotes heart failure after ischemia/reperfusion injury by affecting cardiomyocytes and invading monocytes/macrophages.

Authors:  Maren Heimerl; Irina Sieve; Melanie Ricke-Hoch; Sergej Erschow; Karin Battmer; Michaela Scherr; Denise Hilfiker-Kleiner
Journal:  Basic Res Cardiol       Date:  2020-09-25       Impact factor: 17.165

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.